Ignite Creation Date:
2024-05-06 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 12:49 PM
Study NCT ID:
NCT03583333
Status:
COMPLETED
Last Update Posted:
2023-06-28
First Post:
2018-06-28
Brief Title:
ImipenemCilastatinRelebactam MK-7655A Versus PiperacillinTazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia MK-7655A-016
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-18
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-12
Completion Date Type:
ACTUAL
First Submit Date:
2018-06-28
First Submit QC Date:
June 28 2018
Study First Post Date:
2018-07-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-06-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-27
Last Update Post Date:
2023-06-28
Last Update Post Date Type:
ACTUAL